Disclosure Of Income Tax [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of income tax [text block]		—	—	—	—	—
Major components of tax expense (income) [abstract]
Tax expense (income)	208,000 EUR	—	—	521,000 EUR	—	2,000 EUR
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]	—	—	—	—	—	—
Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets and liabilities [abstract]
Deferred tax liabilities	—	— EUR	— EUR	—	— EUR	—
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]